Fletcher Spaght, Inc. logo

Fletcher Spaght, Inc.

North America, Massachusetts, United States, Boston

Description

Fletcher Spaght, Inc. provides strategy and financial assistance to new ventures including start-ups.

Investor Profile

Fletcher Spaght, Inc. has made 31 investments, with 0 in the past 12 months and 10% as lead.

Stage Focus

  • Series C (35%)
  • Series B (23%)
  • Series D (16%)
  • Series Unknown (13%)
  • Series A (6%)
  • Series E (3%)
  • Debt Financing (3%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Life Science
  • Health Diagnostics
  • Software
  • Genetics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fletcher Spaght, Inc. frequently co-invest with?

Syngenta Ventures
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 7
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
The Aurora Funds
North America, North Carolina, United States, Durham
Co-Investments: 5
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 4
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 3
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 3
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
Early Stage Partners
North America, Ohio, United States, Cleveland
Co-Investments: 4

What are some of recent deals done by Fletcher Spaght, Inc.?

PhaseBio Pharmaceuticals

Malvern, Pennsylvania, United States

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

BiotechnologyMedicalMedical DevicePharmaceutical
Series DSep 5, 2018
Amount Raised: $34,000,000
Cheetah Medical

Newton Center, Massachusetts, United States

Cheetah Medical is a device company developing non-invasive cardiac output and hemodynamic monitoring devices.

BiotechnologyDeveloper PlatformMedical
Series CSep 12, 2017
Amount Raised: $11,760,000
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Series BMar 13, 2017
Amount Raised: $8,260,313
Swift Biosciences

Ann Arbor, Michigan, United States

Swift Biosciences develops molecular biology reagents for research and diagnostic applications.

BiotechnologyHealth CareHealth Diagnostics
Series CApr 15, 2016
Amount Raised: $3,000,000
PhaseBio Pharmaceuticals

Malvern, Pennsylvania, United States

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

BiotechnologyMedicalMedical DevicePharmaceutical
Series CMar 12, 2015
Amount Raised: $40,000,000
CardioFocus

Marlborough, Massachusetts, United States

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

BiotechnologyHealth CareMedical DevicePharmaceutical
Debt FinancingMay 9, 2014
Amount Raised: $2,378,923
Cheetah Medical

Newton Center, Massachusetts, United States

Cheetah Medical is a device company developing non-invasive cardiac output and hemodynamic monitoring devices.

BiotechnologyDeveloper PlatformMedical
Series CFeb 24, 2014
Amount Raised: $28,849,535
Metabolon

Morrisville, North Carolina, United States

Metabolon offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceSoftware
Series EJan 6, 2014
Amount Raised: $14,999,980
Swift Biosciences

Ann Arbor, Michigan, United States

Swift Biosciences develops molecular biology reagents for research and diagnostic applications.

BiotechnologyHealth CareHealth Diagnostics
Series BOct 17, 2013
Amount Raised: $7,000,000
SurgiQuest

Orange, Connecticut, United States

SurgiQuest is a surgical device company in the field of minimally-invasive access technology.

BiotechnologyHealth CareMedicalMedical Device
Series DDec 5, 2012
Amount Raised: $7,500,000